The Renal Center

Filter Your Results

 

News

 

One Question …

February 2012—What is your threshold for treating visceral aneurysms versus watchful waiting?
With Mark D. Morasch, MD, FACS, RPVI; Christopher D. Owens, MD; Nael Saad, MD; and Sanjeeva P. Kalva, MD

ReCor Medical Receives CE Mark Approval for Paradise Renal Denervation System

REGULATORY UPDATE

February 20, 2012—ReCor Medical, Inc. (Ronkonkoma, NY) announced that its Paradise percutaneous renal denervation system has received CE Mark approval for the treatment o…

Medtronic to Study Symplicity Renal Denervation System in Multiple Conditions

February 13, 2012—Medtronic, Inc. (Minneapolis, MN) announced the start of the Global SYMPLICITY Patient Registry and the SYMPLICITY-HF clinical initiatives to evaluate the …

St. Jude Medical Conducts Feasibility Study of Renal Denervation Technology

October 17, 2011—St. Jude Medical, Inc. (St. Paul, MN) announced the commencement of a feasibility study of the company’s renal denervation catheter and generator system. …

FDA Conditionally Approves Medtronic’s SYMPLICITY HTN-3 Renal Denervation Trial

July 11, 2011—Medtronic, Inc. (Minneapolis, MN) announced that the US Food and Drug Administration has conditionally approved the protocol for the SYMPLICITY HTN-3 clinical …

An Interview With Krishna Rocha-Singh, MD

March 2011—A leading interventional cardiologist and clinical trialist discusses new advancements in vascular therapy and his thoughts on the emerging trial data.

Medtronic to Acquire Ardian

November 22, 2010—Medtronic, Inc. (Minneapolis, MN) and Ardian, Inc. (Mountain View, CA) announced that they have entered into a merger agreement whereby Medtronic will acqu…

An Interview With John H. Rundback, MD

August 2010—Reflections on TACIT, what’s next for CREST, and a close look at the field of interventional radiology.

 

advertisement

2017 Device Guide

This Device Guide offers a searchable, comprehensive listing of the available vascular interventional devices in the United States.

 
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.